Skip to main content
Atezolizumab (Tecentriq) bladder cancer indication withdrawn in United States
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Atezolizumab (Tecentriq) bladder cancer indication withdrawn in United States
User login
Username
Password
Reset your password
Concept
Lead
score
Bladder Cancer
1
1
Cancer
0
0.81
Bladder
0
0.63
Biologic Therapy
0
0.62
Hepatocellular Carcinoma
0
0.59
Skin Cancer
0
0.59
Chemotherapy
0
0.25
Immunotherapy
0
0.19
Grant
0
0.06
Liver
0
0.06
Lung
0
0.06
Melanoma
0
0.06
Platinum
0
0.06
Tumor
0
0.06
Specialty
Lead
score
Hematology-Oncology
1
1
Urology
0
0.8
Pharmacist
0
0.7
Internal Medicine
0
0.9
Edit Tags